Informal help is a huge share of elder care in U.S., a burden that is only set to expand. A new book explores different countries’ solutions.

During the early teen years, many new strains of C. acnes colonize the skin on our faces. This could be an optimal time for probiotic treatment.

The circuits could help researchers develop new treatments for Fragile X syndrome and other diseases caused by mutations of a single gene.

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death rates. This may soon no longer be the case.

MIT biologists have found that defects in some transfer RNA molecules can lead to the formation of these common conditions.

New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.

Health Secretary Robert F. Kennedy Jr.’s new vision for US health policy prioritizes deregulation and leaves Americans with fewer benefits, services and protections.

The National Institutes of Health has been integral to scientific progress in treating countless human diseases. Without its support, patients will ultimately pay the price.

A new study finds natural and invented languages elicit similar responses in the brain’s language-processing network.

A new, highly efficient process for performing this conversion could make it easier to develop therapies for spinal cord injuries or diseases like ALS.